Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −4 vs. Q2 2025
- Shares held
- 2.65M
- −54.6K (−2.0%) vs. Q2 2025
- Total value
- $26.0M
- +$6.48M (+33.2%) vs. Q2 2025
- New holders
- 5
- 11 more added
- Sold out
- 9
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 468,199 | $4.59M | 0.02% | −50,101−9.7% | Reduced |
| Deep Track Capital, LP | 444,110 | $4.35M | 0.12% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 412,000 | $4.04M | 0.01% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 335,937 | $3.29M | 0.83% | 00.0% | Unchanged |
| Readystate Asset Management LP | 203,113 | $1.99M | 0.10% | +66,331+48.5% | Added |
| Vanguard Group Inc | 171,689 | $1.68M | 0.00% | +31,913+22.8% | Added |
| Adage Capital Partners GP, L.L.C. | 140,000 | $1.37M | 0.00% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 83,055 | $813.9K | 0.01% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $747.2K | 0.02% | 00.0% | Unchanged |
| LPL Financial LLC | 55,120 | $540.2K | 0.00% | +25,020+83.1% | Added |
| Renaissance Technologies LLC | 55,019 | $539.2K | 0.00% | +2,475+4.7% | Added |
| Geode Capital Management, LLC | 47,080 | $461.6K | 0.00% | +13,032+38.3% | Added |
| Two Sigma Investments, LP | 38,995 | $382.2K | 0.00% | +26,922+223.0% | Added |
| Squarepoint Ops LLC | 30,493 | $298.8K | 0.00% | +11,904+64.0% | Added |
| UBS Group AG | 16,182 | $158.6K | 0.00% | +13,439+489.9% | Added |
| BlackRock, Inc. | 13,040 | $127.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11,284 | $110.6K | 0.00% | +7,279+181.7% | Added |
| Citadel Advisors LLC | 10,310 | $101.0K | 0.00% | −4,888−32.2% | Reduced |
| Susquehanna International Group, LLP | 10,107 | $99.0K | 0.00% | +10,107 | New |
| NorthCrest Asset Manangement, LLC | 10,000 | $98.4K | 0.00% | +10,000 | New |
| Quest Partners LLC | 6,772 | $66.4K | 0.00% | +829+13.9% | Added |
| Wells Fargo & Company | 3,170 | $31.1K | 0.00% | −10,600−77.0% | Reduced |
| Golden State Wealth Management, LLC | 2,674 | $26.2K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,125 | $21.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,914 | $18.8K | 0.00% | −698−26.7% | Reduced |
| Rockefeller Capital Management L.P. | 1,000 | $9.80K | 0.00% | +1,000 | New |
| Global Retirement Partners, LLC | 800 | $7.84K | 0.00% | +800 | New |
| JPMorgan Chase & Co | 708 | $6.94K | 0.00% | +682+2,623.1% | Added |
| Tower Research Capital LLC (TRC) | 457 | $4.48K | 0.00% | −646−58.6% | Reduced |
| SBI Securities Co., Ltd. | 26 | $255 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 15 | $147 | 0.00% | +15 | New |
| ZRC Wealth Management, LLC | 4 | $40 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $29 | 0.00% | −1,813−99.8% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −141,131−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −25,398−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,849−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,315−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,231−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −3,913−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |